January 27, 2015 9:28 PM ET


Company Overview of C Sixty Inc.

Company Overview

C Sixty Inc. is a nanomedicine company that focuses on development of fullerenes based biopharmaceutical products. The company develops fullerene antioxidants that are used in the treatment of central nervous system (CNS) neurodegenerative diseases, strokes, cardiovascular diseases, and other acute and chronic diseases related to oxidative injury. C Sixty was founded in 1999 and is based in Houston, Texas. C Sixty Inc. operates as a subsidiary of Arrowhead Research Corp.

2250 Holcombe Boulevard

Suite 174

Houston, TX 77030

United States

Founded in 1999





Key Executives for C Sixty Inc.

Chief Executive Officer and Director
Age: 58
President and Director
Age: 60
Director of Drug Development
Senior Scientist
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Anti Monkey Butt Corp. United States
GeNO LLC United States
Artax BioPharma Inc. United States
ProDerma Therapeutics, LLC United States
ClinDev Global Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact C Sixty Inc., please visit www.csixty.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.